Related references
Note: Only part of the references are listed.Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
Philippe Colson et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Jianjun Gao et al.
BIOSCIENCE TRENDS (2020)
Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model
Cheng Cui et al.
ACTA PHARMACEUTICA SINICA B (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Prior information for population pharmacokinetic and pharmacokinetic/pharmacodynamic analysis: overview and guidance with a focus on the NONMEM PRIOR subroutine
Anna H. -X. P. Chan Kwong et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2020)
Population-based meta-analysis of roxithromycin pharmacokinetics: dosing implications of saturable absorption and protein binding
Michael J. Dolton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Optimal antimalarial dose regimens for chloroquine in pregnancy based on population pharmacokinetic modelling
Sam Salman et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters
Daniela Milosheska et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border
Richard Hoeglund et al.
MALARIA JOURNAL (2016)
Population pharmacokinetics of azithromycin and chloroquine in healthy adults and paediatric malaria subjects following oral administration of fixed-dose azithromycin and chloroquine combination tablets
Qinying Zhao et al.
MALARIA JOURNAL (2014)
Population-based meta-analysis of hydrochlorothiazide pharmacokinetics
Scott A. Van Wart et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2013)
Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
Martin Bergstrand et al.
AAPS JOURNAL (2011)
Longitudinal aggregate data model-based meta-analysis with NONMEM: approaches to handling within treatment arm correlation
Jae Eun Ahn et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2010)
Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen
Celestino Obua et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Perls-speaks-NONMEM (PsN) - a Perl module for NONMEM related programming
L Lindbom et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2004)
In vitro metabolism of chloroquine:: Identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation
D Projean et al.
DRUG METABOLISM AND DISPOSITION (2003)
Molecular determinants of voltage-dependent human ether-a-go-go related gene (HERG) K+ channel block
JA Sánchez-Chapula et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children
BJ Anderson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
